Rare Diseases

Barry Jones, BPharm

Barry Jones graduated with a Pharmacy degree at the University of London, UK. He spent several years as the Chief Pharmacist for Phoenix Group Pharmacies in Bermuda, before operating a successful Pharmacy business there. He is a former president of the Bermuda Pharmaceutical Association. Since returning to Canada with his family, Barry has been employed with Health Canada and has worked in areas of pre-market activities, post-market surveillance and controlled substances. Presently, Barry is a Senior Policy Analyst with the Office of Pharmaceutical Management Strategies (OPMS) within the Strategic Policy Branch (SPB). His areas of expertise include expensive drugs for rare diseases (orphan drugs), personalised medicine (and targeted therapies), pricing of pharmaceuticals and market access strategies.